Status:

COMPLETED

The Use of Etanercept Enbrel as Sole Treatment for Grade I Acute Graft Versus Host Disease

Lead Sponsor:

University of Michigan Rogel Cancer Center

Conditions:

Acute Graft Versus Host Disease

Eligibility:

All Genders

Phase:

PHASE3

Brief Summary

This is a clinical trial to see if treatment with etanercept for early skin graft-versus-host disease (GVHD) can effectively treat and prevent progression of the disease without using high dose steroi...

Eligibility Criteria

Inclusion

  • Patient must have undergone HCT (donor cells from any source) with either a myeloablative or nonmyeloablative preparative regimen.
  • Patient may be any age.
  • Patient must have biopsy-proven Grade I acute GVHD (Appendix A). Biopsy report does not have to be back from Pathology prior to enrollment. Patients whose biopsy for GVHD identifies pathology inconsistent with GVHD will be removed from the study and replaced. However, because GVHD is a clinical diagnosis, biopsies which are non-diagnostic or do not show a clear non-GVHD etiology will not be cause to remove the patient from the study.

Exclusion

  • Patients who are pregnant (positive urine or serum test) or nursing.
  • Active infections which are unresponsive to antibiotics (\> 2 consecutive \[at least 24 hours apart\], positive blood cultures after initiation of treatment).
  • Allergic or otherwise undesirable reaction to etanercept.
  • Use of any oral or intravenous steroids at any previous time for GVHD treatment. Prior use of steroid therapy (i.e. hydrocortisone) as pre-medication for transfusions is permissible. Prior use of topical steroids is allowed.
  • Use of etanercept for any other purpose.
  • Noncompliance with medications.
  • Grade II-IV GVHD (history of or at time of study entry).

Key Trial Info

Start Date :

May 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 1 2014

Estimated Enrollment :

34 Patients enrolled

Trial Details

Trial ID

NCT00726375

Start Date

May 1 2008

End Date

September 1 2014

Last Update

January 5 2016

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Michigan

Ann Arbor, Michigan, United States, 48109

The Use of Etanercept Enbrel as Sole Treatment for Grade I Acute Graft Versus Host Disease | DecenTrialz